Skip to main content

Peer Review reports

From: Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection

Original Submission
22 Feb 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 May 2024 Reviewed Reviewer Report
9 May 2024 Reviewed Reviewer Report
28 May 2024 Author responded Author comments - Fariborz Brumandpur
Resubmission - Version 3
28 May 2024 Submitted Manuscript version 3
30 May 2024 Author responded Author comments - Fariborz Brumandpur
Resubmission - Version 4
30 May 2024 Submitted Manuscript version 4
10 Jun 2024 Reviewed Reviewer Report
12 Jun 2024 Reviewed Reviewer Report
14 Jun 2024 Author responded Author comments - Fariborz Brumandpur
Resubmission - Version 5
14 Jun 2024 Submitted Manuscript version 5
Publishing
17 Jun 2024 Editorially accepted
21 Jun 2024 Article published 10.1186/s12886-024-03528-0

You can find further information about peer review here.

Back to article page